중환자실에서 적용한 반코마이신(Vancomycin) 내성 장구균의 감염관리 전략 효과

Effects of Infection Control Strategies for Vancomycin Resistant Enterococci in Intensive Care Units

  • Choi, Kyung-Ok (Graduate School, The Catholic University of Korea) ;
  • Kim, Nam-Cho (College of Nursing, The Catholic University of Korea)
  • 투고 : 2009.05.20
  • 심사 : 2009.08.26
  • 발행 : 2009.08.31

초록

Purpose: This study was to examine whether VRE infection control strategies have an effect on the decrease in incidence rates for VRE acquisition and VRE nosocomial infection in ICU. Methods: All the patients were examined for VRE carriers on ICU admission. Among them, patients hospitalized for over 48 hours were investigated for VRE acquisition rates and VRE nosocomial infection rate using VRE infection control strategies in ICU for the experimental group from September 2007 to April 2008. Before that, incidence of VRE acquisition and VRE nosocomial infection for the control group without Intervention were investigated from May to August 2007 retrospectively. Results: VRE acquisition rate in clinical specimens was 0.6% in the experimental group, that was significantly lower when compared to the control group. VRE carrier rate at admission to ICU was 15.4%. Out of 182 VRE carriers, 180 patients were identified by the active surveillance culture. Conclusion: These results suggested that active surveillance culture at admission was considered to be an essential measure for detection of VRE carrier. But without strict isolation and adherence rating after each intervention, hand washing and contact isolation alone did not significantly decrease VRE nosocomial infection, although it did significantly decrease incidence of VRE acquired from clinical specimen.

키워드

참고문헌

  1. Cheong, H. J., Song, J. Y., Eom, J. S., Kim, W. J., Choi, S. J., Choi, J. H., Lee, H., Chung, M. H., Lee, K. M., Shin, D. H., Sohn, B. R., Choi, J. S., Woo, H. J., Kwon, J. A., Lee, K. W., Choe, K. W., & Park, S. C. (2002). Colonization rate, risk factor for acquisition and genetic diversity of vancomycin resistant enterococci isolated from rectal culture of patients in intensive care units from ten large hospitals in Korea. Korean Journal of Infectious Disease, 34(5), 276-284.
  2. Choi, S. J., Kim, D. R., Cheong, H. J., Kim, W. J., Kim, M. J., & Park, S. C. (1999). Detection of rectal VRE carriers and control in the ICU of an university Hospital. Korean Journal of Nosocomial Infection Control, 4(1), 284.
  3. Furtado, G. H., Martins, S. T., Coutinho, A. P., Wey, S. B., & Medeiros, E. A. (2005). Prevalence and factors associated with rectal vancomycin resistant enterococci colonization in two intensive care units in Sao Paulo, Brazil. The Brazilian Journal of Infectious Disease, 9(1), 64-69.
  4. Hayden, M. K., Bonten, M. J., Blom, D. W., Lyle, E. A., van de Vijver D. A., & Weinstein, R. A. (2006). Reduction in acquisition of vancomycin resistant enterococci after enforcement of routine environmental cleaning measures. Clinical Infectious Disease, 42(11), 1552-1560. https://doi.org/10.1086/503845
  5. Kim, D. R., Yu, C. W., Cheong, H. J., Woo, H. J., Choi, S. J., Kim, W. J., & Park, S. C. (2001). Rectal surveillance culture of vancomycin resistant enterococci(VRE) colonization among patient hospitalized in the intensive care unit. Journal of the Korea Society for chemotherapy, 19(2), 87-97.
  6. Kim, J. M., Park, E. S., Jeong, J. S., Kim, K. M., Kim, J. M., Oh, H. S., Yoon, S. W., Lee, S. I., Lee, M. S., Song, J. H., Kang, M. W., Choe, K. W., Park, S. C., & Pai, C. H. (1997). 1996 National nosocomial infection surveillance in Korea. Korean Journal of Nosocomial Infection Control, 2(2), 157-176.
  7. Kim, K. M., Yoo, J. H., Choi, J. H., Park, E. S., Kim K. S., Kim, K. S., Kim, S. R., Kim S. M., Kim, H. J., Jung, J. S., Yoo, K. H., Oh, H. S., Yoon, S. W., Suh, M. R., & Yoon, Y. K. (2006). The Nationwide surveillance results of nosocomial infections along with antimicrobial resistance in intensive care units of sixteen university hospitals in Korea, 2004. Korean Journal of Nosocomial Infection Control, 11(2), 79-86.
  8. Laclercq, R., Derlot, E., Duval, J., & Courvalin, P. (1988). Plasmidmediated resistance to vancomycin and teicoplanin in Enterococcus faecium. The New England Journal of Medicine, 319(3), 157-161. https://doi.org/10.1056/NEJM198807213190307
  9. Lee, S. O., Kim, S. D., Lee, J. S., Kim, K. M., Kim, B. H., Kim, E. S., Kim, J. H., Kim, T. H., Kim, H. Y., Park, S. W., Pai, H. J., Uh, Y., Lee, E. S., Jang, Y. S., Chang, Y. J., Han, M. J., Kang, J. O., Kim, M. N., Kim, M. J., Park, E. S., Oh, H. S., Jeong, J. S., Lee, Y. S., Oh, H. B., & Choi, T. Y. (2006). Korean nosocomial infections surveillance system (KONIS) report: Data summary from July through September 2006. Korean Journal of Nosocomial Infection Control, 11(2), 113-128.
  10. Maclntyre, C. R., Empson, M., Boardman, C., & Sindhusake, D. (2001). Risk factors for colonization with vancomycin resistant enterococci in a Melbourne hospital. Infection Control and Hospital Epidemiology, 22(10), 624-631. https://doi.org/10.1086/501833
  11. Mayhall, C. G. (2004). Hospital Epidemiology and Infection Control(3rd ed.). Philadelphia: Lippincott Williams & Wilkins, 1659-1700.
  12. McNeil, S. A., Malani, P. N., Chenoweth, C. E., Fontana, R. J., Magee, J. C., Punch, J. D., Mackin, M. L., & Kauffman, C. A. (2006). Vancomycin resistant enterococcal colonization and infection in liver transplant candidates and recipients: A prospective surveillance study. Clinical Infectious Disease. 42(1), 195-203. https://doi.org/10.1086/498903
  13. Metallidis, S., Chatzidimitriou, M., Tsona, A., Bisiklis, A., Laza, K. E., Gikas, A., Alexiou, D. S., & Nikolaidis, P.. (2006). Vancomycin resistant enterococci, colonizing the intestinal tract of patients in a university hospital in Greece. The Brazilian Journal of Infectious Disease, 10(3), 179-184. https://doi.org/10.1590/S1413-86702006000300005
  14. Montecalvo, M. A., Jarvis, W. R., Uman, J., Shay, D. K., Petrullo, C., Rodney, K., Gedris, C., Horowitz, H. W., & Wormser, G. P. (1999). Infection control measures reduce transmission of vancomycin resistant enterococci in an endemic setting. Annals of Internal Medicine, 131(4), 269-272. https://doi.org/10.7326/0003-4819-131-4-199908170-00006
  15. Muto, C. A., Jernigan, J. A., Ostrowky, B. E., Richet, H. M., Jarvis, W. R., Boyce, J. M., & Farr, B. M. (2003). SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of staphylococcus aureus and enterococcus. Infection Control and Hospital Epidemiology, 24(5), 362-386. https://doi.org/10.1086/502213
  16. Ostrowky, B. E., Venkataraman, L., D'Agata E. M., Gold, H. S., DeGirolami, P. C., & Samore, M. H. (1999). Vancomycin resistant enterococci in intensive care units. Archives of Internal Medicine, 159(13), 1467-1472. https://doi.org/10.1001/archinte.159.13.1467
  17. Park, J. W., Kim, Y. R., Shin, W. S., Kang, M. W., Han, K. J., & Shim, S. I. (1992). Susceptibility test of vancomycin resistant enterococci. Korean Journal of Infectious Disease, 24(2), 133-137.
  18. Pelz, R, K., Lipsett, P, A., Swoboda, S, M., West, M, D., Powe, N, R., Brower, R, G., Perl, T, M., Hammond, J. M., & Hendrix, C. W. (2002). Vancomycin-sensitive and vancomycin resistant enterococcal infections in the ICU: Attributable costs and outcomes. Intensive Care Medicine, 28(6), 692-697. https://doi.org/10.1007/s00134-002-1276-8
  19. Peta, M., Carretto, E., Barbarim, D., Zamperoni, A., Carnevale, L., Perversi, L., Pagani, M., Bonora, G., Fontana, R., Marone, P., & Langer, M. (2006). Outbreak of vancomycin resistant enterococcus spp. in an Italian general intensive care unit. Clinical Microbiology and Infection, 12(2), 163-169. https://doi.org/10.1111/j.1469-0691.2005.01331.x
  20. Shadel, B. N., Puzniak, L. A., Gillespie, K. N., Lawrence, S. J., Kollef, M., & Mundy, L. M. (2006). Surveillance for vancomycin resistant enterococci: Type, rates, costs, and implications. Infection Control and Hospital Epidemiology, 27(10), 1068-1075. https://doi.org/10.1086/507960
  21. Siddigui, A. H., Harris, A. D., Hebden, J., Wilson, P. D., Morris, J. G., & Roghmann, M. C. (2002). The effect of active surveillance for vancomycin resistant enterococci in high-risk units on VRE incidence hospital-wide. American Journal of Infection Control, 30(1), 40-43. https://doi.org/10.1067/mic.2002.118616
  22. Song, X., Srinvasan, A., Plaut, D., & Perl, T. M. (2003). Effect of nosocomial vancomycin resistant enterococcal bacteremia on mortality, length of stay, and costs. Infection Control and Hospital Epidemiology, 24(4), 251-256. https://doi.org/10.1086/502196
  23. Stosor, V., Peterson, L. R., Postelnick, M., & Noskin, G. A. (1998). Enterococcus faecium bacteremia; does vancomycin resistance make a difference? Archives of Internal Medicine, 158(5), 522-527. https://doi.org/10.1001/archinte.158.5.522
  24. Yeh, K. M., Siu, L. K., Chang, J. C., & Chang, F. Y. (2004). Vancomycin resistant enterococci(VRE) carriage and infection in intensive care units. Microbial Drug Resistance, 10(2), 177-183. https://doi.org/10.1089/1076629041310091
  25. Yoon, S. W., Peck, K. R., Kim, O. S., Lee, J. H., Lee, N. Y., Oh, W. S., & Song, J. H. (2007). Efficacy of infection control strategies to reduce transmission of vancomycin resistant enterococci in a tertiary care hospital in Korea: A 4-years follow-up study. Infection Control and Hospital Epidemiology, 28(4), 493-495. https://doi.org/10.1086/513024
  26. Warren, D. K., Kollef, M. H., Seiler, S. M., Fridkin, S. K., & Fraser, V. J. (2003). The epidemiology of vancomycin resistant enterococci colonization in a medical intensive care unit. Infection Control and Hospital Epidemiology, 24(4), 238-241. https://doi.org/10.1086/502206